In th
|
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
|
Youth with special healthcare needs are at increased risk for obesity and associated co-morbidities.
|
In this webinar, we will focus on deepening attendees understanding of the pathophysiology, diagnosis, and treatment of various comorbidities associated with childhood obesity. Dr.
|
Sarcopenia is becoming increasingly prevalent in the aging population with obesity, causing osteopenia, frailty, muscular weakness, and increased risk for falls.
|
Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health.
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
In this session Dr. Jakicic delves into the critical role of physical activity and exercise in obesity treatment.
|
A case definition of lipedema is an important, practical step forward in identifying how lipedema is diagnosed and distinct from usual obesity. Join us for this upcoming webinar where we will desc
|
Nonviolent communication (NVC) developed by Dr.
|